Anti-USAG-1 therapy for tooth regeneration through enhanced BMP signaling

 

Abstract

Uterine sensitization-associated gene-1 (USAG-1) deficiency leads to enhanced bone morphogenetic protein (BMP) signaling, leading to supernumerary teeth formation. Furthermore, antibodies interfering with binding of USAG-1 to BMP, but not lipoprotein receptor-related protein 5/6 (LRP5/6), accelerate tooth development. Since USAG-1 inhibits Wnt and BMP signals, the essential factors for tooth development, via direct binding to BMP and Wnt coreceptor LRP5/6, we hypothesized that USAG-1 plays key regulatory roles in suppressing tooth development. However, the involvement of USAG-1 in various types of congenital tooth agenesis remains unknown. Here, we show that blocking USAG-1 function through USAG-1 knockout or anti-USAG-1 antibody administration relieves congenital tooth agenesis caused by various genetic abnormalities in mice. Our results demonstrate that USAG-1 controls the number of teeth by inhibiting development of potential tooth germs in wild-type or mutant mice missing teeth. Anti-USAG-1 antibody administration is, therefore, a promising approach for tooth regeneration therapy.

  • 1402/12/08
  • - تعداد بازدید: 33
  • زمان مطالعه : کمتر از یک دقیقه
Conference report Advanced Therapies Week 2023

Conference report Advanced Therapies Week 2023

.

The Advanced Therapies Week 2023 conference took place in Miami, FL, USA. Over the course of 4 days packed with talks, panels, company showcases and networking events, a clear message emerged: the future of cell therapy is here. Timely topics covered by speakers and panelists from industry and academia included allogeneic and autologous cell therapies, cell manufacture automation, cell and gene therapy for autoimmune diseases, gene delivery technology, chimeric antigen receptor T-cell therapy in oncology, closed cell therapy manufacturing and how to serve small patient populations. While some challenges remain, this decade will likely witness the US FDA approval of many cell and gene therapies, as well as new devices for their manufacture.

 
 
  • گروه خبری : اخبار و اطلاعیه ها
  • کد خبری : 76906
کلیدواژه

نظرات

0 نظر برای این مطلب وجود دارد

نظر دهید